CLB
Get informed when a big investor buys or sells
+ FollowOvervalued by 15.4% based on the discounted cash flow analysis.
| Market cap | $465.12 Million |
|---|---|
| Enterprise Value | $481.69 Million |
| Dividend Yield | $0.04 (0.40%) |
| Earnings per Share | $0.68 |
| Beta | 1.14 |
| Outstanding Shares | 46,878,000 |
| P/E Ratio | 18.02 |
|---|---|
| PEG | -40.95 |
| Price to Sales | 0.89 |
| Price to Book Ratio | 1.95 |
| Enterprise Value to Revenue | 0.93 |
| Enterprise Value to EBIT | 10.08 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.14 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.91% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.07%▼ 115.54% |
|---|---|
| Total Invested | $304,095▼ 99.95% |
| Investors Holding | 4▼ 185.00% |
No data
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...